Success Metrics

Clinical Success Rate
89.3%

Based on 201 completed trials

Completion Rate
89%(201/225)
Active Trials
41(11%)
Results Posted
33%(67 trials)
Terminated
24(6%)

Phase Distribution

Ph phase_1
19
5%
Ph phase_2
52
14%
Ph phase_3
82
22%
Ph early_phase_1
10
3%
Ph phase_4
119
32%
Ph not_applicable
81
22%

Phase Distribution

29

Early Stage

52

Mid Stage

201

Late Stage

Phase Distribution363 total trials
Early Phase 1First-in-human
10(2.8%)
Phase 1Safety & dosage
19(5.2%)
Phase 2Efficacy & side effects
52(14.3%)
Phase 3Large-scale testing
82(22.6%)
Phase 4Post-market surveillance
119(32.8%)
N/ANon-phased studies
81(22.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.4%

201 of 247 finished

Non-Completion Rate

18.6%

46 ended early

Currently Active

41

trials recruiting

Total Trials

376

all time

Status Distribution
Active(54)
Completed(201)
Terminated(46)
Other(75)

Detailed Status

Completed201
unknown73
Recruiting37
Terminated24
Withdrawn22
Not yet recruiting10

Development Timeline

Analytics

Development Status

Total Trials
376
Active
41
Success Rate
89.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 110 (2.8%)
Phase 119 (5.2%)
Phase 252 (14.3%)
Phase 382 (22.6%)
Phase 4119 (32.8%)
N/A81 (22.3%)

Trials by Status

completed20153%
recruiting3710%
active_not_recruiting41%
suspended21%
terminated246%
not_yet_recruiting103%
unknown7319%
enrolling_by_invitation31%
withdrawn226%

Recent Activity

Clinical Trials (376)

Showing 20 of 376 trialsScroll for more
NCT02314988Phase 2

Tranexamic Acid to Reduce Blood Loss in Spine Surgery

Recruiting
NCT06414031Phase 3

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Recruiting
NCT06208267Not Applicable

Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty

Recruiting
NCT02702128Phase 3

Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery

Completed
NCT06599762Phase 2

Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Recruiting
NCT06422273Phase 3

Protest Trial: TXA vs Saline

Enrolling By Invitation
NCT07501884Phase 4

REDUCER Trial (TXA in Urethroplasty)

Not Yet Recruiting
NCT05370820Phase 2

Prevention of Postpartum Hemorrhage With Tranexamic Acid

Recruiting
NCT07481682Not Applicable

Impact of Inhaled Tranexamic Acid in Pulmonary Hemorrhage in Pediatric Intensive Care Unit

Completed
NCT07460518Phase 4

Tranexamic Acid for Bleeding Reduction During TURP Surgery

Not Yet Recruiting
NCT03128866Early Phase 1

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

Active Not Recruiting
NCT07432737Not Applicable

One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures

Recruiting
NCT03552705Phase 2

The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients

Recruiting
NCT04905901Phase 3

Nebulized Tranexamic Acid in Sinus Surgery

Recruiting
NCT07410130

Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate

Not Yet Recruiting
NCT07390799Not Applicable

Prophylactic Tranexamic Acid in Low-Risk Repeat Cesarean Delivery: A Randomized Controlled Trial

Not Yet Recruiting
NCT05053867Phase 3

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

Recruiting
NCT05345613Phase 4

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Recruiting
NCT04448184Phase 3

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

Recruiting
NCT05323149Phase 3

Tranexamic Acid in Traumatic Brain Injury

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
376